Related references
Note: Only part of the references are listed.Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections
Leonard Amaral et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine
Eduardo Abbate et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Cytochrome b Mutation Y268S Conferring Atovaquone Resistance Phenotype in Malaria Parasite Results in Reduced Parasite bc1 Catalytic Turnover and Protein Expression
Nicholas Fisher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
Myungsun Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid Focus on Antifungal, Antitubercular and Miscellaneous Anti-Infective Agents
Keith A. Rodvold et al.
CLINICAL PHARMACOKINETICS (2011)
Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid Focus on Antibacterial Agents
Keith A. Rodvold et al.
CLINICAL PHARMACOKINETICS (2011)
New tuberculosis drugs on the horizon
Stewart T. Cole et al.
CURRENT OPINION IN MICROBIOLOGY (2011)
Reduction of Clofazimine by Mycobacterial Type 2 NADH: Quinone Oxidoreductase A PATHWAY FOR THE GENERATION OF BACTERICIDAL LEVELS OF REACTIVE OXYGEN SPECIES
Takahiro Yano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Reaction Mechanism of Single Subunit NADH-Ubiquinone Oxidoreductase (Ndi1) from Saccharomyces cerevisiae EVIDENCE FOR A TERNARY COMPLEX MECHANISM
Yu Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism
Jennifer E. Griffin et al.
PLOS PATHOGENS (2011)
Inhibiting Plasmodium cytochrome bc1: a complex issue
Victoria Barton et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Respiratory ATP synthesis: the new generation of mycobacterial drug targets?
Dirk Bald et al.
FEMS MICROBIOLOGY LETTERS (2010)
Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis
Jurriaan E. M. de Steenwinkel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis
Dick van Soolingen et al.
PLOS ONE (2010)
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Andreas H. Diacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Antimalarial drugs - What is in use and what is in the pipeline
Martin Schlitzer
ARCHIV DER PHARMAZIE (2008)
Promising Therapy of XDR-TB/MDR-TB with Thioridazine an Inhibitor of Bacterial Efflux Pumps
L. Amaral et al.
CURRENT DRUG TARGETS (2008)
Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis
Anil Koul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis
Srinivasa P. S. Rao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Thioridazine: resurrection as an antimicrobial agent?
H. K. R. Thanacoody
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
New insight into the mechanism of action of and resistance to isoniazid:: Interaction of Mycobacterium tuberculosis enoyl-ACP reductase with INH-NADP
Argyrides Argyrou et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Circumventing the crabtree effect: Replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants
Lisa D. Marroquin et al.
TOXICOLOGICAL SCIENCES (2007)
Diarylquinolines target subunit c of mycobacterial ATP synthase
Anil Koul et al.
NATURE CHEMICAL BIOLOGY (2007)
Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein
Ruben C. Hartkoorn et al.
TUBERCULOSIS (2007)
Synthesis and antitubercular activity of quaternized promazine and promethazine derivatives
Aaron B. Bate et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis
Marta Martins et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Steady-state kinetics and inhibitory action of antitubercular phenothiazines on Mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2)
T Yano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates
ZF Xie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Inhibitors of type IINADH:-menaquinone oxidoreductase represent a class of antitubercular drugs
EA Weinstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Electron transfer ability from NADH to menaquinone and from NADPH to oxygen of type IINADH dehydrogenase of Corynebacterium glutamicum
N Nantapong et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2005)
The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism -: Novel insights into drug mechanisms of action
HIM Boshoff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
New insights into Type II NAD(P)H:quinone oxidoreductases
AMP Melo et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2004)
The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase:: Adduct affinity and drug resistance
R Rawat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Genetic requirements for mycobacterial survival during infection
CM Sassetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Genes required for mycobacterial growth defined by high density mutagenesis
CM Sassetti et al.
MOLECULAR MICROBIOLOGY (2003)
Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis
D Ordway et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I
HI Boshoff et al.
JOURNAL OF BACTERIOLOGY (2002)
Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death
AH Glassman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates
ASG Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG
B Murugasu-Oei et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Simple redox-linked proton-transfer design: new insights from structures of quinol-fumarate reductase
T Ohnishi et al.
STRUCTURE (2000)
Share Paper
